Loss of the Y chromosome drives bladder cancer by altering immune cell functionality, while simultaneously making these cells more vulnerable to immune checkpoint inhibitor treatments, a paper in Nature has shown.
Loss of Y chromosome drives bladder cancer
Image by Peter Artymiuk via the Wellcome Collection. Depicts the shadow of a DNA double helix, on a background that shows the fluorescent banding of the output from a DNA sequencing machine.
